First Bank & Trust Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Bank & Trust decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,202 shares of the medical equipment provider’s stock after selling 230 shares during the period. First Bank & Trust’s holdings in Intuitive Surgical were worth $3,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC raised its stake in Intuitive Surgical by 23.0% in the 4th quarter. Concurrent Investment Advisors LLC now owns 12,145 shares of the medical equipment provider’s stock worth $6,339,000 after acquiring an additional 2,272 shares during the last quarter. Meitav Investment House Ltd. purchased a new position in Intuitive Surgical in the 4th quarter worth $209,000. Handelsbanken Fonder AB raised its stake in Intuitive Surgical by 32.8% in the 4th quarter. Handelsbanken Fonder AB now owns 255,743 shares of the medical equipment provider’s stock worth $133,488,000 after acquiring an additional 63,201 shares during the last quarter. Mcdaniel Terry & Co. raised its stake in Intuitive Surgical by 0.5% in the 4th quarter. Mcdaniel Terry & Co. now owns 70,499 shares of the medical equipment provider’s stock worth $36,798,000 after acquiring an additional 334 shares during the last quarter. Finally, Private Wealth Partners LLC raised its stake in shares of Intuitive Surgical by 6.4% during the 4th quarter. Private Wealth Partners LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 87 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. UBS Group lifted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 in the last ninety days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $608.48 on Thursday. The stock has a market cap of $216.73 billion, a P/E ratio of 94.93, a P/E/G ratio of 5.74 and a beta of 1.39. The stock’s 50 day simple moving average is $563.17 and its 200-day simple moving average is $522.88. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.